Poultry Vaccines Market Size (2024 - 2029)

The poultry vaccines market is projected to experience significant growth over the forecast period, driven by the increasing demand for poultry products and the need for effective disease management strategies. The expansion of poultry production globally, coupled with rising awareness about the importance of vaccination in maintaining flock health and productivity, is a key factor contributing to the market's growth. Additionally, advancements in vaccine technology, including the development of new and improved vaccines, are enhancing the efficacy and convenience of disease prevention in poultry. These factors collectively indicate a robust increase in the market size of poultry vaccines.

Market Size of Poultry Vaccines Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Poultry Vaccines Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 1.39 Billion
Market Size (2029) USD 1.7 Billion
CAGR (2024 - 2029) 4.20 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Poultry Vaccines Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Poultry Vaccines Market Analysis

The Poultry Vaccines Market size is estimated at USD 1.39 billion in 2024, and is expected to reach USD 1.7 billion by 2029, growing at a CAGR of 4.20% during the forecast period (2024-2029).

Poultry farming is a vital industry in the global food sector, providing a significant source of protein. However, diseases pose a constant threat to poultry health, leading to economic losses for farmers and impacting food security. To combat this challenge, the use of vaccines in the poultry industry has become increasingly prevalent. Over the years, the poultry vaccines market has witnessed substantial growth, driven by various factors such as increasing poultry production, rising awareness about disease prevention, and advancements in vaccine technology.

One of the primary drivers behind the growth of the poultry vaccines market is the expansion of poultry production worldwide. With growing populations and rising incomes in many regions, there is a greater demand for poultry products. For instance, according to the United Nations, the global population could grow to around 8.5 billion by 2030, 9.7 billion by 2050, and 10.4 billion by 2100. Consequently, farmers are scaling up their operations to meet this demand, leading to larger poultry populations that require effective disease management strategies.

Farmers are increasingly recognizing the importance of preventive measures in maintaining the health and productivity of their poultry flocks. Vaccination is seen as a proactive approach to disease management, offering protection against a wide range of viral and bacterial pathogens. By vaccinating their birds, farmers can significantly reduce the risk of disease outbreaks, resulting in improved flock health and productivity.

Advancements in vaccine technology have also played a crucial role in driving the growth of the poultry vaccines market. Researchers and manufacturers are continually developing new and improved vaccines that offer better efficacy, safety, and convenience. This includes the development of recombinant vaccines, vector vaccines, and novel delivery systems, providing farmers with a broader range of options to protect their poultry flocks.

Thus, due to the above-mentioned factors, the market is expected to witness substantial growth during the forecast period.

Poultry Vaccines Industry Segmentation

Vaccines help prevent diseases by boosting the immune system to produce antibodies, which, in turn, fight against organisms such as Salmonella, E. coli, and Mycoplasma gallisepticum (MG). Vaccines offer protection from diseases like Marek's disease, infectious bronchitis (IB), avian rhinotracheitis (ART), Newcastle disease, and infectious bursal disease (Gumboro disease).

The poultry vaccines market is segmented by diseases (bronchitis, avian influenza, Newcastle Disease, Marek's disease, and others), technology (recombinant vaccines, inactivated vaccines, live attenuated vaccines (LAV), and others), and geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and South America). The report offers the value (in USD) for the above segments.

By Disease
Bronchitis
Avian Influenza
Newcastle disease
Marek's Disease
Others
By Technology
Recombinant Vaccines
Inactivated Vaccines
Live Attenuated Vaccines (LAV)
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Poultry Vaccines Market Size Summary

The poultry vaccines market is experiencing significant growth, driven by the increasing demand for poultry products and the need for effective disease management strategies. As poultry farming remains a crucial component of the global food industry, the threat of diseases like avian influenza poses substantial risks to both poultry health and economic stability. The market is expanding due to the rising awareness of disease prevention and advancements in vaccine technology, which offer farmers improved options for protecting their flocks. The development of novel vaccines, including recombinant and vector vaccines, is enhancing the efficacy and convenience of disease management in poultry farming. This proactive approach to vaccination is essential for maintaining flock health and productivity, thereby supporting the growing global demand for poultry products.

In North America, the poultry vaccines market is poised for substantial growth, supported by increased consumption of poultry-derived products and heightened consumer awareness of food safety. The region's market is bolstered by significant investments in research and development, leading to innovations in vaccine technology. Collaborations among pharmaceutical companies, biotechnology firms, and research institutions are driving the development of advanced vaccines and therapeutics. Key players in the market are actively engaging in strategic partnerships and acquisitions to strengthen their market presence. The ongoing efforts to address avian influenza outbreaks through vaccination and other control measures are crucial for ensuring the sustainable growth of the poultry industry, particularly in regions like North America where the demand for poultry products continues to rise.

Explore More

Poultry Vaccines Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Incidences of Poultry and Zoonotic Diseases

      2. 1.2.2 Widened Focus on Food Safety

    3. 1.3 Market Restraints

      1. 1.3.1 Use of Counterfeit Medicine

      2. 1.3.2 Increasing Costs of Animal Testing and Veterinary Services

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 2.1 By Disease

      1. 2.1.1 Bronchitis

      2. 2.1.2 Avian Influenza

      3. 2.1.3 Newcastle disease

      4. 2.1.4 Marek's Disease

      5. 2.1.5 Others

    2. 2.2 By Technology

      1. 2.2.1 Recombinant Vaccines

      2. 2.2.2 Inactivated Vaccines

      3. 2.2.3 Live Attenuated Vaccines (LAV)

      4. 2.2.4 Others

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Poultry Vaccines Market Size FAQs

The Poultry Vaccines Market size is expected to reach USD 1.39 billion in 2024 and grow at a CAGR of 4.20% to reach USD 1.7 billion by 2029.

In 2024, the Poultry Vaccines Market size is expected to reach USD 1.39 billion.

Poultry Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)